Purchase Order 75N95D20P00147

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Meso Scale Diagnostics LLC, a Native American-owned small business, for $12,891.50 on August 12, 2020. The order is for MA6000 384 plate pake (120 plate) under firm fixed price with no set-aside category. Place of performance is Gaithersburg, Maryland. Ultimate completion date is September 11, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Meso Scale Diagnostics LLC for $13,945.50 on March 6, 2020, for MA6000 384 SA plate packs (120 plate). The awardee is a Native American-owned small business. Place of performance is Rockville, Maryland. Ultimate completion date is March 5, 2021.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Meso Scale Diagnostics LLC, a Native American-owned small business, for $13,097.62 on September 10, 2020. Place of performance is Bethesda, Maryland. The order, issued under firm fixed price, carries an ultimate completion date of October 10, 2020. The source does not specify the items or services procured.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Meso Scale Diagnostics LLC for $37,750.20 on April 5, 2018. The order is set aside for total small business and carries a firm fixed price. Meso Scale Diagnostics is a Native American-owned small business. Work is performed in Rockville, Maryland. The order is for biomarker biologicals, with an ultimate completion date of December 15, 2018.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Meso Scale Diagnostics LLC on March 19, 2021, with a ceiling value of $55,000.00 for firm fixed price supply of biomedical research technologies and assay kits. Meso Scale Diagnostics is a Native American-owned small business located in Rockville, Maryland. Work is performed in Rockville, Maryland. The order was issued under unrestricted full and open competition without a small business set-aside; the...

<p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Meso Scale Diagnostics LLC for $55,000.00 on December 15, 2020, for a MESO QuickPlex SQ 120MM Reader equipment to analyze tissues in support of COVID-19 research. Meso Scale Diagnostics is a Native American-owned small business. Place of performance is Rockville, Maryland. The order carries a firm fixed price and an ultimate completion date of February 1, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Meso Scale Diagnostics LLC for $10,570.00 on December 9, 2020, for V-PLEX SARS-CoV-2 panels supporting COVID-19 research. The awardee is a Native American-owned small business. Performance occurs in Rockville, Maryland, with completion by December 15, 2020. The order is firm fixed price with no set-aside.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Meso Scale Diagnostics LLC, a Native American-owned small business, valued at $11,774.50 on February 2, 2021, with final completion on March 2, 2021. The order was issued on a firm fixed price basis with no small business set-aside. Work is performed at the awardee's location in Bethesda, Maryland.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Meso Scale Diagnostics LLC for a V-PLEX PROINFLAM Panel at $7,497.80 on August 23, 2017. The awardee is a Native American-owned small business. Performance was completed in Bethesda, Maryland, with an ultimate completion date of February 22, 2018. The purchase order was issued on a firm fixed price basis with no set-aside category applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Meso Scale Diagnostics LLC for $148,989.10 on August 16, 2021, for procurement of a custom U-PLEX biomarker set. The awardee is a Native American-owned small business. Work is performed at the awardee's location in Bethesda, Maryland. The order, funded under the Coronavirus COVID-19 National Interest Action, has an ultimate completion date of November 1, 2021, and is priced on a firm fixed price basis.</p>